Dr Veronica de Chavez about the Trimetazidine
About the event
What do you think about the Trimetazidine class recommendation upgrade from Iib to IIa in the 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes?
Dr. Veronica de Chavez shares with us how the new guidelines reinforced her confidence in Trimetazidine for her patients.
Why use Trimetazidine in coronary diabetic patients?
Dr. Veronica de Chavez shares with us the clinical benefits she has observed with Trimetazidine in coronary diabetic patients.
What is your experience with Trimetazidine in clinical practice?
Dr. Veronica de Chavez shares with us her clinical experience with Trimetazidine.
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events